BIO
BIO
ReciBioPharm is advancing the T7 polymerase field by combining a robust knowledge library and advanced screening techniques to identify the optimal polymerase for each xRNA construct. Through this innovative process development approach, RecibioPharm is accelerating development timelines, reducing costs, and setting new benchmarks for efficiency and quality in RNA manufacturing.